gp100 (25 - 33) (human)
| Name | gp100 (25 - 33) (human) |
| Category | Cancer Research Peptides |
| One Letter Code | KVPRNQDWL |
| Three Letter Code | {Lys}{Val}{Pro}{Arg}{Asn}{Gln}{Asp}{Trp}{Leu} |
| Molecular Weight | 1155.300 |
| Application | Cancer Research |
| Overwijk, Willem W., et al. "gp100/pmel 17 is a murine tumor rejection antigen: induction of “self”-reactive, tumoricidal T cells using high-affinity, altered peptide ligand." The Journal of experimental medicine 188.2 (1998): 277-286. |
| Wang, Li-Xin, et al. "Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing." Cancer research 65.22 (2005): 10569-10577. |
| Finkelstein, Steven E., et al. "Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer." Journal of leukocyte biology 76.2 (2004): 333-337. |